×

Diagnosis & Therapy

Vaccine may restore NSCLC response to checkpoint inhibitors

Vaccine may restore NSCLC response to checkpoint inhibitors

Diagnosis & TherapyBY CHRISTINE KILGORE MDedge News SAN FRANCISCO – An experimental allogeneic cellular vaccine combined with the checkpoint inhibitor nivolumab (Opdivo) may boost the immune response in patients with previously treated non–small cell lung cancer...

read more
Neoadjuvant atezolizumab shrinks NSCLC tumors

Neoadjuvant atezolizumab shrinks NSCLC tumors

Diagnosis & TherapyBY CHRISTINE KILGORE MDedge News SAN FRANCISCO – One-fifth of patients with resectable non–small cell lung cancer had a major pathologic response to neoadjuvant therapy with the immune checkpoint inhibitor atezolizumab (Tecentriq), according to...

read more

Continue Reading


Biomarkers


+

Prevention


+

Cost And Coping


+

Diagnosis and Therapy


+

Patient Journey


+